[Identification of anomalous coronary arteries and their anatomic course by multidetector computed tomography coronarography. A retrospective registry]. / L'utilisation du scanner cardiaque multibarrettes pour l'exploration des anomalies coronaires. Analyse d'une série rétrospective monocentrique.

BACKGROUND: The coronary anomalies are generally asymptomatic and rare. However, their potential complications are serious and mainly represented by the risk of sudden death. The coronarography appears insufficient to carry out the complete assessment of these anomalies, and in particular to study the arterial course. The endpoint of our series is to evaluate the interest of the coronary computed tomography (CT) in this indication. PATIENTS AND METHODS: We report the results of a 16-slice coronary-CT monocentric retrospective series among 12 patients presenting coronary anomalies diagnosed in coronarography. RESULTS: Coronary-CT has confirmed the diagnosis, specified the coronary course and the relation with the great vessels in 100% of the cases. CONCLUSIONS: Multislice coronary-CT seems an examination of choice for the diagnosis and the presurgical assessment of the coronary aberrations, like for the distinction of the benign and malign forms. Its effectiveness and its "non-invasive" character are strong arguments to include it in the assessment of syncopes linked to effort in the young adult.

[Multidetector computed tomography coronarography: preliminary experience in real life settings]. / Scanner coronaire: bilan d'une expérience préliminaire dans le cadre de la vraie vie.

UNLABELLED: Multidetector computed tomography coronarography (MDCT) is a promising tool, offering non invasive anatomic evaluation of coronary arteries. We relate in this article our impressions after our first two years experience. METHODS: Retrospective study of the 328 patients who underwent MDCT examination between January 2005 and December 2006 at our community hospital. Per patient comparative analysis of the anatomical findings versus percutaneous angiography (PCA) in 61 cases. RESULTS: Out of 328 patients 61 (18.5%) underwent PCA. In these patients we found a sensibility, specificity, positive predictive value and negative predictive value of 100%, 54%, 59% and 100% for MDCT. The main factor responsible for inconclusive vessel analysis was excessive calcification. CONCLUSION: In routine use, MDCT enables one to rule out significant stenosis non invasively, with high sensitivity in an unselected patient population.

[Atrial electrophysiological study of unexplained ischemic cerebrovascular disorders]. / Exploration électrophysiologique auriculaire des accidents vasculaires ischémiques cérébraux inexpliqués.

The aim of this study was to search for the presence of atrial vulnerability by programmed atrial stimulation in patients with unexplained ischaemic cerebrovascular strokes and to evaluate the effects of intravenous flecainide acetate on the electrophysiological parameters and on the induction of atrial arrhythmias. Thirty-eight patients (20 men, 18 women) with a mean age of 38.4 +/- 11 years were investigated. Programmed atrial pacing triggered a sustained (> 1 min) atrial arrhythmia with 1 or 2 extrastimuli in 23 of the 38 patients (61%), in these patients, there was a significant shortening of the effective refractory periods (ERP: 193 +/- 23 vs 218 +/- 30 ms; p < 0.02) and of the functional refractory periods (FRP: 228 +/- 25 vs 253 +/- 27 ms; p < 0.01) with lengthening of the A2 auriculogramme (99.7 +/- 22 vs 76.1 +/- 16 ms; p < 0.05). A combined study of the refractory periods and conduction defects provides a means of calculating an index of latent vulnerability which is greatly shortened when an atrial arrhythmia is induced (2 +/- 0.5 cm vs 3 +/- 0.6 cm; p < 0.001). Atrial arrhythmias could not be initiated after intravenous 3 mg/kg of flecainide acetate in 4 subjects (17%) with initially positive atrial stimulation tests. This study confirms the high frequency of atrial vulnerability in patients with unexplained ischaemic cerebrovascular strokes. In their population, the authors observed a low efficacy of flecainide acetate in the prevention of reinduction of atrial arrhythmias. The indication of long-term antiarrhythmic drugs in these patients are questionnable and should be assessed by a prospective long-term multicentre trial.

[Results, complications and long-term follow-up of percutaneous ablation of atrioventricular conduction. Apropos of 85 cases]. / Résultats, complications et suivi au long cours de l'ablation percutanée de la conduction auriculo-ventriculaire. A propos de 85 observations.

This retrospective study reports the immediate and long-term results of percutaneous ablation of atrioventricular conduction. Between July 1983 and January 1992, 85 consecutive patients (51 men, age 64 +/- 10 years, range 43-84 years) presenting with supraventricular arrhythmias (atrial fibrillation n = 53; atrial flutter n = 50; atrial tachycardia n = 17; junctional tachycardia n = 6) resistant to antiarrhythmic therapy (number of drugs used: 4 +/- 1.3, range 1-6) underwent interruption of atrioventricular conduction by fulguration (n = 65) or radiofrequency energy (n = 13) or by an association of the two methods (n = 7). The 75 pacemakers implanted (10 patients had pacemakers before the procedure) comprised 55 VVIR, 11 VVI, 5 DDD and 4 DDDR units. The immediate results included two sudden deaths at the 4th and 7th day in patients undergoing fulguration and three complications with a favourable outcome (staphylococcal septicaemia, pulmonary embolism and haematoma at the site of implantation of the pacemaker). None of the patients was lost to follow-up and the average follow-up was 31 +/- 18 months (range 2-108 months). During follow-up, 15 patients died and there was a recurrence of symptoms in 11 patients after 1 to 9 months requiring a repeat procedure. In the 68 survivors, the follow-up is now 38 +/- 18 months (range 12-108 months). Sixty one patients have 2nd (2) or 3rd (59) degree atrioventricular block, giving 90% good electrocardiographic results.(ABSTRACT TRUNCATED AT 250 WORDS)

[Value of permanent cardiac pacing in hypertrophic and obstructive cardiomyopathies resistant to medical treatment]. / Intérêts de la stimulation cardiaque permanente dans les myocardiopathies hypertrophiques et obstructives rebelles au traitement médical.

The authors report their experience of long-term dual-chamber pacing in the treatment of hypertrophic and obstructive cardiomyopathy. Between August 1990 and March 1993, 16 patients (8 men, average age 53.5 +/- 18.9 years, range 21 and 79 years) with symptomatic hypertrophic obstructive cardiomyopathy resistant to medical therapy underwent electrophysiological investigation to assess atrioventricular conduction and the effects of temporary atrioventricular pacing on the intraventricular pressure gradient before implantation of a dual-chamber pacing system. The decision to implant was taken if the endocavitary studies showed severe atrioventricular conduction defects and/or if temporary pacing reduced the systolic pressure gradient by more than 30%. Temporary dual-chamber pacing led to a decrease of 48% of the systolic pressure gradient from 78.6 +/- 21.3 to 40.1 +/- 23.6 mmHg (p < 0.0005), a regression observed in 15 of the 16 patients. After an average follow-up period of 18.7 +/- 9.5 months (range 6 and 37 months), all 15 patients who received a dual-chamber pacing system were alive and were clinically improved. The systolic pressure gradient continued to decrease during the follow-up period (24.4 +/- 17.2 mmHg at the 6th month compared with 36.5 +/- 18.6 mmHg at the time of implantation; p = 0.014). The clinical improvement was dependent on careful adjustment of the atrioventricular delay which was programmed at relatively short values (65.6 +/- 14 ms, range 47 and 75 ms) to obtain permanent right ventricular capture. The authors conclude that dual-chamber pacing is an effective means of treating symptomatic hypertrophic obstructive cardiomyopathy resistant to medical therapy, even in the absence of preexisting conduction defects.

[Left-sided His bundle ablation after failure of right-sided approach: technique and initial results]. / Ablation du faisceau de His par voie gauche après échec d'un abord droit: technique et résultats préliminaires.

Although interruption of atrioventricular conduction has been widely used over the last decade in patients with supraventricular arrhythmias and rapid conduction resistant to antiarrhythmic therapy, the incidence of atrioventricular block obtained by delivering the energy at the tricuspid ring ranges from 45 to 92%. Failure of this technique is usually related to the inhability to record endocavitary electrogrammes compatible with probable success by the right-sided approach. The authors report four cases of interruption of atrioventricular conduction in 4 men (average age 61.5 +/- 10 years) by the retrograde arterial catheterisation after one or more (1 to 3) failures by the right-sided approach. After arterial puncture, the ablation catheter is positioned against the interventricular septum below the aortic cusps to record the His bundle electrogram. His bundle ablation was obtained after an average of 2 radio frequency energy applications (range 1 to 3). At the time of effective application, the average amplitude of the endocavitary electrogram was as follows: auriculogram 0.09 mV (range 0.05 to 0.2 mV), His bundle electrogram 0.19 mV (0.15-0.22 mV), ventriculogram 1.36 mV (1.0 to 1.7 mV). No complications were observed. After an average follow-up of 4 months, the 4 patients were still in complete atrioventricular block. This preliminary series shows that left-sided interruption of atrioventricular conduction is effective and safe. It may be proposed after failure of a right-sided attempt.

[Implantable defibrillator using epicardial and endocardial leads. Results of 36 implantations]. / Défibrillateur implantable par système épicardique et endocardique. A propos de 36 implantations.

The authors report their experience of implantable defibrillators over a 5 year period. Between February 1988 and July 1992, 36 patients (25 men, 11 women, average age 51 +/- 11 years, range 18 +/- 71 years) underwent implantation of an automatic defibrillator with epicardial (n = 13, Group I) or endocardial leads (n = 23, Group II) without patch electrodes (n = 7), with subcutaneous patch electrodes (n = 12) or epicardial patch electrodes (n = 4). Three serious early complications were observed: 2 cardiogenic shocks in Group I, one of which died on Day 1 and one case of infection which required explanation of the defibrillator on Day 23 in Group II. Late complications in Group I included one case of disactivation of the defibrillator, 2 losses of output, one of which required replacement of the defibrillator and 2 increases of threshold treated by implantation of an endocardial lead. In Group II, 2 patients had inappropriate shocks due to overdetection (n = 1) and double counting (n = 1). During an average follow-up period of 28.5 +/- 9 months in group I and 13 +/- 6 months in Group II, 4 patients died, 2 from sudden death. Ninety seven shocks were delivered in 19 patients (56%), 5.1 shocks per patient. In the 17 patients with an antitachycardia function, 14 (82%) developed 947 episodes of VT treated successfully by antitachycardia pacing in 917 cases. This retrospective study confirms the efficacy of implantable defibrillators in the treatment of malignant ventricular arrhythmias. The efficacy of endocardial and epicardial leads seems to be the same but there seems to be a lower immediate mortality and morbidity with the endocardial system.